LLY

764

+2.13%↑

JNJ

176.45

-0.55%↓

ABBV

216.08

-0.77%↓

UNH

339.82

-2.33%↓

AZN

77.61

-0.58%↓

LLY

764

+2.13%↑

JNJ

176.45

-0.55%↓

ABBV

216.08

-0.77%↓

UNH

339.82

-2.33%↓

AZN

77.61

-0.58%↓

LLY

764

+2.13%↑

JNJ

176.45

-0.55%↓

ABBV

216.08

-0.77%↓

UNH

339.82

-2.33%↓

AZN

77.61

-0.58%↓

LLY

764

+2.13%↑

JNJ

176.45

-0.55%↓

ABBV

216.08

-0.77%↓

UNH

339.82

-2.33%↓

AZN

77.61

-0.58%↓

LLY

764

+2.13%↑

JNJ

176.45

-0.55%↓

ABBV

216.08

-0.77%↓

UNH

339.82

-2.33%↓

AZN

77.61

-0.58%↓

Search

Thermo Fisher Scientific Inc

Cerrado

SectorSanidad

480.67 1.27

Resumen

Variación precio

24h

Actual

Mínimo

472.19

Máximo

484.38

Métricas clave

By Trading Economics

Ingresos

100M

1.6B

Ventas

491M

11B

P/B

Media del Sector

28.172

35.664

BPA

5.15

Rentabilidad por dividendo

0.33

Margen de beneficios

14.878

Empleados

125,000

EBITDA

1.1B

2.8B

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+15.38% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.33%

3.12%

Próximas Ganancias

22 oct 2025

Fecha Próximo Dividendo

15 oct 2025

Próxima Fecha de Ex Dividendo

12 dic 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

31B

184B

Apertura anterior

479.4

Cierre anterior

480.67

Puntuación técnica

By Trading Central

Confianza

Bearish Evidence

Thermo Fisher Scientific Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

23 jul 2025, 10:33 UTC

Ganancias

Thermo Fisher Scientific 2Q Profit, Revenue Rise

25 jun 2025, 21:19 UTC

Adquisiciones, fusiones, absorciones

Solventum Removes Drinking-Water Unit From Thermo Fisher's Planned Filtration Buy

28 may 2025, 14:02 UTC

Adquisiciones, fusiones, absorciones

Brookfield, Caisse de Depot Buy Antylia Scientific From GTCR for $1.34 Billion

23 abr 2025, 10:33 UTC

Ganancias

Thermo Fisher 1Q Net, Revenue Up, Costs Stable

25 feb 2025, 14:05 UTC

Adquisiciones, fusiones, absorciones

Thermo Fisher Scientific to Acquire Solventum's Filtration Unit, Confirming WSJ Report

2 sept 2025, 12:15 UTC

Adquisiciones, fusiones, absorciones

Thermo Fisher Scientific Completes Acquisition Of Sanofi's Ridgefield, New Jersey Site >TMO

2 sept 2025, 12:08 UTC

Adquisiciones, fusiones, absorciones

Solventum Had Seen 2025 Adjusted EPS $5.80-$5.95 >SOLV

2 sept 2025, 12:08 UTC

Adquisiciones, fusiones, absorciones

Solventum Raises 2025 View To Adj EPS $5.88-Adj EPS $6.03 >SOLV

2 sept 2025, 12:04 UTC

Adquisiciones, fusiones, absorciones

Solventum to Use Net Proceeds Primarily to Pay Down Debt >SOLV

2 sept 2025, 12:03 UTC

Adquisiciones, fusiones, absorciones

Solventum Closes Sale of Unit to Thermo Fisher for $4 Billion in Cash >SOLV

2 sept 2025, 12:03 UTC

Adquisiciones, fusiones, absorciones

Thermo Fisher Completes Acquisition of Purification & Filtration Business of Solventum for About $4B in Cash >TMO

2 sept 2025, 12:00 UTC

Adquisiciones, fusiones, absorciones

Solventum Completes Sale of Purification & Filtration Business to Thermo Fisher Scientific >SOLV TMO

23 jul 2025, 10:00 UTC

Ganancias

Thermo Fisher 2Q Organic Revenue Rose 2% >TMO

23 jul 2025, 10:00 UTC

Ganancias

Thermo Fisher 2Q Adj EPS $5.36 >TMO

23 jul 2025, 10:00 UTC

Ganancias

Thermo Fisher 2Q Net $1.62B >TMO

23 jul 2025, 10:00 UTC

Ganancias

Thermo Fisher 2Q EPS $4.28 >TMO

23 jul 2025, 10:00 UTC

Ganancias

Thermo Fisher 2Q Rev $10.85B >TMO

14 jul 2025, 16:12 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Waters Closer to Thermo Fisher, Danaher With Becton Dickinson Unit -- Market Talk

14 jul 2025, 15:06 UTC

Adquisiciones, fusiones, absorciones

Waters Stock Is Falling on Deal to Combine With Becton Dickinson Unit -- Barrons.com

28 may 2025, 13:47 UTC

Adquisiciones, fusiones, absorciones

Brookfield, Caisse de Depot Buy Antylia Scientific From GTCR for $1.34B

23 abr 2025, 10:01 UTC

Ganancias

Thermo Fisher 1Q Adjusted Operating Margin 21.9% >TMO

23 abr 2025, 10:00 UTC

Ganancias

Thermo Fisher 1Q Organic Revenue Rose 1% >TMO

23 abr 2025, 10:00 UTC

Ganancias

Thermo Fisher 1Q EPS $3.98 >TMO

23 abr 2025, 10:00 UTC

Ganancias

Thermo Fisher 1Q Rev $10.36B >TMO

23 abr 2025, 10:00 UTC

Ganancias

Thermo Fisher 1Q Adj EPS $5.15 >TMO

23 abr 2025, 10:00 UTC

Ganancias

Thermo Fisher 1Q Net $1.51B >TMO

25 feb 2025, 14:09 UTC

Adquisiciones, fusiones, absorciones

Thermo Fisher Strikes Deal for Solventum's Filtration Unit -- WSJ

25 feb 2025, 13:41 UTC

Adquisiciones, fusiones, absorciones

Solventum: Transaction Is Expected to Be Completed by End of 2025 >SOLV

25 feb 2025, 13:40 UTC

Adquisiciones, fusiones, absorciones

Solventum Expects Estimated $3.4 B in Net Proceeds >SOLV

25 feb 2025, 13:40 UTC

Adquisiciones, fusiones, absorciones

Solventum: Deal Strengthens Balance Sheet With Proceeds to Be Used Primarily for Debt Paydown >SOLV

Comparación entre iguales

Cambio de precio

Thermo Fisher Scientific Inc previsión

Precio Objetivo

By TipRanks

15.38% repunte

Estimación a 12 Meses

Media 547.42 USD  15.38%

Máximo 590 USD

Mínimo 500 USD

De acuerdo con 20 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Thermo Fisher Scientific Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

20 ratings

17

Comprar

3

Mantener

0

Vender

Puntuación técnica

By Trading Central

406.5 / 417.79Soporte y Resistencia

Corto Plazo

Bearish Evidence

Medio plazo

Bearish Evidence

Largo Plazo

Strong Bearish Evidence

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquar
help-icon Live chat